178 related articles for article (PubMed ID: 22036018)
1. Aspirin and colorectal cancer prevention in Lynch syndrome.
Chan AT; Lippman SM
Lancet; 2011 Dec; 378(9809):2051-2. PubMed ID: 22036018
[No Abstract] [Full Text] [Related]
2. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial.
Burn J; Sheth H; Elliott F; Reed L; Macrae F; Mecklin JP; Möslein G; McRonald FE; Bertario L; Evans DG; Gerdes AM; Ho JWC; Lindblom A; Morrison PJ; Rashbass J; Ramesar R; Seppälä T; Thomas HJW; Pylvänäinen K; Borthwick GM; Mathers JC; Bishop DT;
Lancet; 2020 Jun; 395(10240):1855-1863. PubMed ID: 32534647
[TBL] [Abstract][Full Text] [Related]
3. Does aspirin really reduce the risk of colon cancer?
Cleland JG
Lancet; 2012 Apr; 379(9826):1586; author reply 1587. PubMed ID: 22541575
[No Abstract] [Full Text] [Related]
4. Does aspirin really reduce the risk of colon cancer?
Jankowski J; Barr H; Moayyedi P
Lancet; 2012 Apr; 379(9826):1586-7; author reply 1587. PubMed ID: 22541573
[No Abstract] [Full Text] [Related]
5. Daily aspirin reduces colorectal cancer incidence in patients with Lynch syndrome.
Barton MK
CA Cancer J Clin; 2012; 62(3):143-4. PubMed ID: 22411104
[No Abstract] [Full Text] [Related]
6. Aspirin Colorectal Cancer Prevention in Lynch Syndrome: Recommendations in the Era of Precision Medicine.
Serrano D; Patrignani P; Stigliano V; Turchetti D; Sciallero S; Roviello F; D'Arpino A; Grattagliano I; Testa S; Oliani C; Bertario L; Bonanni B
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328014
[TBL] [Abstract][Full Text] [Related]
7. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
Burn J; Gerdes AM; Macrae F; Mecklin JP; Moeslein G; Olschwang S; Eccles D; Evans DG; Maher ER; Bertario L; Bisgaard ML; Dunlop MG; Ho JW; Hodgson SV; Lindblom A; Lubinski J; Morrison PJ; Murday V; Ramesar R; Side L; Scott RJ; Thomas HJ; Vasen HF; Barker G; Crawford G; Elliott F; Movahedi M; Pylvanainen K; Wijnen JT; Fodde R; Lynch HT; Mathers JC; Bishop DT;
Lancet; 2011 Dec; 378(9809):2081-7. PubMed ID: 22036019
[TBL] [Abstract][Full Text] [Related]
8. Aspirin may help colon cancer patients live longer.
Harv Health Lett; 2013 Jan; 38(3):8. PubMed ID: 23556168
[No Abstract] [Full Text] [Related]
9. Chemoprevention in Lynch syndrome.
Burn J; Mathers JC; Bishop DT
Fam Cancer; 2013 Dec; 12(4):707-18. PubMed ID: 23880960
[TBL] [Abstract][Full Text] [Related]
10. General practitioner attitudes towards prescribing aspirin to carriers of Lynch Syndrome: findings from a national survey.
Smith SG; Foy R; McGowan J; Kobayashi LC; Burn J; Brown K; Side L; Cuzick J
Fam Cancer; 2017 Oct; 16(4):509-516. PubMed ID: 28434157
[TBL] [Abstract][Full Text] [Related]
11. RE: Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome.
Tuccori M; Filion KB; Azoulay L
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26711870
[No Abstract] [Full Text] [Related]
12. Aspirin and the prevention of colorectal cancer.
Ferrández A; Piazuelo E; Castells A
Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):185-95. PubMed ID: 22542156
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of colorectal neoplasia.
Wakeman C; Keenan J; Eteuati J; Hollington P; Eglinton T; Frizelle F
ANZ J Surg; 2017 Dec; 87(12):E228-E232. PubMed ID: 26686322
[TBL] [Abstract][Full Text] [Related]
14. Approach to Lynch Syndrome for the Gastroenterologist.
Bui QM; Lin D; Ho W
Dig Dis Sci; 2017 Feb; 62(2):299-304. PubMed ID: 27990589
[TBL] [Abstract][Full Text] [Related]
15. Non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention.
Hawk ET; Viner J; Richmond E; Umar A
Cancer Chemother Biol Response Modif; 2003; 21():759-89. PubMed ID: 15338773
[No Abstract] [Full Text] [Related]
16. Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.
Ait Ouakrim D; Dashti SG; Chau R; Buchanan DD; Clendenning M; Rosty C; Winship IM; Young JP; Giles GG; Leggett B; Macrae FA; Ahnen DJ; Casey G; Gallinger S; Haile RW; Le Marchand L; Thibodeau SN; Lindor NM; Newcomb PA; Potter JD; Baron JA; Hopper JL; Jenkins MA; Win AK
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26109217
[TBL] [Abstract][Full Text] [Related]
17. Lynch syndrome: history, causes, diagnosis, treatment and prevention (CAPP2 trial).
Burn J; Mathers J; Bishop DT
Dig Dis; 2012; 30 Suppl 2():39-47. PubMed ID: 23207931
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
[TBL] [Abstract][Full Text] [Related]
19. Response.
Ait Ouakrim D; Dashti SG; Win AK
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26711871
[No Abstract] [Full Text] [Related]
20. Exploring clinicians' attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer.
Chen Y; Peate M; Kaur R; Meiser B; Wong T; Kirk J; Ward RL; Goodwin A; Macrae F; Hiller J; Trainer AH; Mitchell G
Fam Cancer; 2017 Jan; 16(1):99-109. PubMed ID: 27677266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
